SCHEMBL7218944

SCHEMBL7218944

CC1(c2ccc(O)cc2)CSc2cc(O)ccc2C1CCCCCCCCC(CCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.54
AR P10275 1/20 0.33
NR1I2 O75469 1/20 0.30
NR3C1 P04150 1/20 0.30
PGR P06401 1/20 0.30
ESRRA P11474 1/20 0.30
EPHX2 P34913 1/20 0.30
PPARG P37231 1/20 0.30
ESR2 Q92731 1/20 0.30
NR1H4 Q96RI1 1/20 0.30
SIRT5 Q9NXA8 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
ALOX15 P16050 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7219789 1.00 ESR1 (0.54) ESR1ARNR1I2NR3C1PGR
SCHEMBL7225982 0.99 ESR1 (0.54) ESR1ARNR1I2NR3C1PGR
SCHEMBL7221154 0.98 ESR1 (0.52) ESR1AR
SCHEMBL7225027 0.98 ESR1 (0.52) ESR1AR
SCHEMBL7221248 0.98 ESR1 (0.52) ESR1AR
SCHEMBL7219515 0.98 ESR1 (0.52) ESR1AR
SCHEMBL7128075 0.94 ESR1 (0.47) ESR1ARNR1I2NR3C1PGR
SCHEMBL7124146 0.94 ESR1 (0.47) ESR1ARNR1I2NR3C1PGR
SCHEMBL7117919 0.94 ESR1 (0.47) ESR1ARNR1I2NR3C1PGR
SCHEMBL7119240 0.94 ESR1 (0.47) ESR1ARNR1I2NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552069-B1 Having anti-estrogenic activity; for use in therapy CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-22 US claimed
EP-1241166-A1 3-METHYL-CHROMAN AND -THIOCHROMAN DERIVATIVES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-09-18 EP claimed
US-6552069-B1 Having anti-estrogenic activity; for use in therapy CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-22 US disclosed
EP-1241166-A1 3-METHYL-CHROMAN AND -THIOCHROMAN DERIVATIVES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-09-18 EP disclosed